Oakridge International Limited has reported a striking turnaround in its half-year results, posting a profit after tax of $172,239 against a prior loss, driven by strong sales and product innovation in healthcare technology.
- 61.9% increase in revenue to $1.79 million
- Profit after tax of $172,239, reversing prior loss
- Growth driven by healthcare technology sales and NuCaMS platform enhancements
- No dividend declared amid ongoing operational cash outflows
- Strategic partnerships and cloud integration underpin positive outlook
Financial Turnaround
Oakridge International Limited has delivered a notable financial turnaround in the half-year ended 31 December 2025, reporting a profit after tax of $172,239 compared to a loss of $126,968 in the same period last year. This improvement was underpinned by a 61.9% increase in revenue to $1.79 million, reflecting sustained momentum in sales and project delivery within its healthcare technology segment.
Driving Growth Through Healthcare Technology
The company’s core business of selling professional healthcare technology equipment, including its proprietary nurse call systems and assisted living solutions, has seen robust demand. Oakridge’s NuCaMS and NuCaMS Enterprise platforms have been enhanced with improved reporting, scalability, and compliance with the new AS8311 – 2024 Nurse Call Standard, positioning the company competitively in a growing market. Integration with Microsoft Azure for cloud-based Single Sign-On further supports scalable enterprise deployments.
Operational and Strategic Advances
Operationally, Oakridge has strengthened its nationwide distribution partnerships and improved internal systems with the adoption of Zoho Books and inventory platforms, enhancing communication and stock management. Digital marketing efforts have increased brand visibility, contributing to a healthy pipeline of quotes and tenders for FY2026. Despite these positive developments, the company has not declared a dividend, reflecting a cautious approach amid ongoing cash outflows from operations.
Financial Position and Risks
While profitability has returned, Oakridge continues to experience cash outflows from operating activities, with a net cash outflow of $480,634 for the half-year. The company has secured a $215,000 interest-free short-term advance from a director-associated entity to support liquidity. Contingent liabilities related to past agreements remain unresolved, including potential legal exposures from a share placement agreement and obligations tied to a subsidiary’s grant loan. The directors maintain confidence in the company’s going concern status, supported by expected future cash flows and capital raising capabilities.
Looking Ahead
Oakridge enters the second half of FY2026 with operational momentum and a robust project pipeline, particularly in healthcare technology and IoT-enabled assisted living solutions. The company’s focus on product development, strategic partnerships, and market expansion suggests a positive trajectory, though investors will be watching closely for improvements in cash flow and resolution of contingent liabilities.
Bottom Line?
Oakridge’s return to profitability and strong revenue growth mark a promising phase, but cash flow challenges and contingent risks warrant close investor attention.
Questions in the middle?
- How will Oakridge manage ongoing cash outflows despite profitability?
- What is the potential impact of unresolved contingent liabilities on future financial health?
- Can the company convert its strong project pipeline into sustained revenue growth?